1: Shu Y, Lei H, Tan YN, Meng M, Zhang XC, Liu CY. Tuning the electronic coupling in Mo2-Mo2 systems by variation of the coordinating atoms of the bridging ligands. Dalton Trans. 2014 Oct 21;43(39):14756-65. doi: 10.1039/c4dt00786g. PubMed PMID: 25157859.
2: Abergel RJ, Raymond KN. Multidentate terephthalamidate and hydroxypyridonate ligands: towards new orally active chelators. Hemoglobin. 2011;35(3):276-90. doi: 10.3109/03630269.2011.560771. PubMed PMID: 21599440.
3: Leyden R, Velasco-Torrijos T, André S, Gouin S, Gabius HJ, Murphy PV. Synthesis of bivalent lactosides based on terephthalamide, N,N'-diglucosylterephthalamide, and glycophane scaffolds and assessment of their inhibitory capacity on medically relevant lectins. J Org Chem. 2009 Dec 4;74(23):9010-26. doi: 10.1021/jo901667r. PubMed PMID: 19899775.
4: Procacci P, Ferrari F, Bettini G, Bissolotti G, Trevisiol L, Nocini PF. Soccer-related facial fractures: postoperative management with facial protective shields. J Craniofac Surg. 2009 Jan;20(1):15-20. doi: 10.1097/SCS.0b013e3181909c55. PubMed PMID: 19164981.
5: Abergel RJ, Raymond KN. Synthesis and thermodynamic evaluation of mixed hexadentate linear iron chelators containing hydroxypyridinone and terephthalamide units. Inorg Chem. 2006 May 1;45(9):3622-31. PubMed PMID: 16634594; PubMed Central PMCID: PMC3685440.
6: Yin H, Lee GI, Sedey KA, Rodriguez JM, Wang HG, Sebti SM, Hamilton AD. Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction. J Am Chem Soc. 2005 Apr 20;127(15):5463-8. PubMed PMID: 15826183.
7: Yin H, Hamilton AD. Terephthalamide derivatives as mimetics of the helical region of Bak peptide target Bcl-xL protein. Bioorg Med Chem Lett. 2004 Mar 22;14(6):1375-9. PubMed PMID: 15006365.
8: Kraft A, Peters L, Fröhlich R. N,N',N",N"'-Tetraethylterephthalamidinium bis(tetrazolate). Acta Crystallogr C. 2002 May;58(Pt 5):o272-4. Epub 2002 Apr 11. PubMed PMID: 11983988.
9: Rodriguez GI, Kuhn JG, Weiss G, De La Cruz P, New P, Fields SM, Eckardt JR, Campbell L, Clark GM, Hilsenbeck SG, Von Hoff DD. A phase I and pharmacokinetic trial of terephthalamidine (NSC 57155) as a 120-hour continuous infusion. Invest New Drugs. 1998;16(1):57-67. PubMed PMID: 9740545.
10: Fisherman JS, Cline EM, Plowman J, Quinn FR, Hawkins MJ. Terephthalamidine: past and future. Invest New Drugs. 1991 Nov;9(4):295-303. Review. PubMed PMID: 1804802.
11: Waud WR, Hill DL. High-performance liquid chromatographic determination of terephthalamidine in plasma. J Chromatogr. 1988 Mar 4;425(1):220-6. PubMed PMID: 3360873.
12: Voyksner RD, Williams FP, Hines JW. Analysis of candidate anticancer drugs by thermospray high-performance liquid chromatography-mass spectrometry and by high-resolution mass spectrometry. J Chromatogr. 1985 Oct 25;347(1):137-46. PubMed PMID: 4086628.
13: Winkler A, Kreis W, Gregg VC, Purple JR, Burchenal JH. In vitro and in vivo studies of the antileukemic action of n,n'-bos [p-(n'-methylamidino)phenyl]terephthalamidine, tetrahydrochloride (NSC 57155) on P815 leukemic cells. Cancer Res. 1966 Jul;26(7):1502-7. PubMed PMID: 5916484.